NEW YORK – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter fell nearly 4 percent year over year. The reason for the decline was the inclusion of revenue from its divested Cynosure Medical Aesthetics business in the year-ago quarter.
Hologic posted $822.9 million in total revenues for the quarter, compared to $852.4 million in the year-ago period. It handily beat the consensus Wall Street revenue estimate of $616.7 million. Excluding material acquisitions and divestitures, organic revenue grew nearly 8 percent in the quarter.